Absolutely mate. there's no way we don't get to 2 cents on a quality acquisition. We have the cash and the management team / contacts to get something juicy. Will continue to accumulate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025